You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Oct 17, 2025

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Jessica A Canter1, Sarah E Ernst1, Kristin M Peters1
1Department of Biological Sciences, Towson University, Towson, MD 21252, USA.
The 15 kDa selenoprotein (Selenof) deficiency reduced aberrant crypt foci but did not alter tumor development in a mouse model. Selenof may influence intestinal barrier integrity and cell structure, impacting tumor type.
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
06:24Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
Published on: October 13, 2023
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: